查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1146144

早產和 PROM 測試市場 - 增長、趨勢、COVID-19 影響和預測 (2022-2027)

Preterm Birth and PROM Testing Market - Growth, Trends, And Forecasts (2022 - 2027)
出版日期: | 出版商: Mordor Intelligence | 英文 120 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

在預測期內 (2022-2027)，早產和 PROM 檢測市場預計將以 3.35% 的複合年增長率增長。

COVID-19 大流行對早產和 PROM 檢測市場產生了重大影響。根據 2020 年 10 月發表在國際婦產科雜誌上的題為“COVID-19 大流行對孕產婦健康的影響”的研究，“COVID-19 大流行導致人們尋求醫療護理。延遲對孕產婦健康的影響”。來自三級中心的經驗”，三分之一的婦女沒有進行足夠的產前檢查。坐月子和害怕感染是延誤就醫的主要原因，44.7% 的妊娠以併發症告終。此外，2020 年 7 月發表在《婦產科調查》上的一份報告發現，懷孕期□□間感染 COVID-19 會增加早產、胎膜早破等妊娠並發症的風險，在極少數情況下還會導致孕產婦死亡。 因此，早產和 PROM 檢測正在興起，用於產前檢測和預防並減少併發症。因此，由於對護理的需求不斷增加，市場預計會上漲。

市場增長的驅動因素包括全球範圍內早產和低出生體重的增加、床旁診斷的進步和 PROM 測試工具的技術進步，以及對早產和 PROM 測試可用性的認識的提高。

早產率和早產兒死亡率上升是預測期內市場增長的主要驅動力。美國疾病控制與預防中心公佈的數據顯示，2021年，14.9%的非裔美國女性會早產，比白人（9.1%）和西班牙裔女性（9.8%）高出50個百分點。同樣，March of Dimes 發布的統計數據證實，到 2021 年，黑人女性的早產率將從 14.25% 上升到 14.36%，美洲印第安人/阿拉斯加原住民母親的早產率將從 11.55% 上升到 11.61%。此外，在美國疾病控制與預防中心2021年發表的一篇題為《早產》的論文中，據報導，2020年，美國出生的嬰兒中有十分之一會早產。

此外，越來越多的人前往診斷實驗室和醫療機構進行檢測，尤其是在新興地區，這也有助於預測期內的市場擴張。診斷中心正變得越來越流行和廣泛使用，因為它們具有更高的可靠性、成本效益、更快的結果以及以更低的成本提供準確的診斷結果。

然而，不可用的 PROM 檢查服務和欠發達國家的經濟限制可能會阻礙市場增長。

主要市場趨勢

預計超音波業務在預測期內將保持較高的複合年增長率

由於早產發生率的增加、公司研發活動的增加以及檢測和預測早產的技術進步等因素，預計超聲診斷領域在預測期內將出現顯著增長。

因為超音波掃描會產生子宮和嬰兒的圖像，它們可以用來檢查宮頸組織，看看宮頸是否擴張或脫出，也可以用來提高診斷和預測早產。我可以做吧。

隨著早產發生率和相關後果的增加，孕婦更有可能在懷孕期間進行早產檢測，以安撫和監測早產症狀並避免過早死亡。例如，發表在美國家庭醫生雜誌上的一篇論文證實，到 2020 年，大約 3% 的懷孕將並發早產 PROM，其中三分之一的早產被確定為原因。它會導致一些圍產期和新生兒問題，包括增加早產風險和 1-2% 的胎兒死亡機率。

越來越多的公司專注於開發預測早產的測試和設備，這也促進了診斷超聲領域的增長，這反過來又推動了市場增長。例如，2022年3月，Ultrasound AI Inc.將利用超聲技術和人工智能預測早產，實現更早干預。此外，2021 年 5 月，DC Medical 將在謝菲爾德大學研究電阻抗譜 (EIS)，以開發一種便攜式早產診斷設備 EveryBaby，它認為這可能會提高預測早產的準確性。 2020 年 8 月，以色列初創公司 PulseNmore 推出了一款手持式遠程超聲設備，孕婦可以在家中進行超聲檢查，並接收醫生和超音波醫師的反饋。

因此，由於與早產相關的發病率和風險不斷增加以及技術進步，預計在預測期內診斷超聲領域的需求將會增加。

預計北美將佔據較大的市場份額

由於早產的增加導致產前檢測需求增加、技術創新的進步和醫療設施的增強等因素，預計北美將佔據很大的市場份額。

此外，在該地區，不僅公司而且非營利組織都在專注於開髮用於評估和檢測早產的測試和設備，為市場的增長做出貢獻。例如，2021 年 1 月，Sera Prognostics, Inc. 與 HealthCore, Inc. 和 Anthem, Inc. 合作啟動了 PRIME 試驗，評估臨床干預和 PreTRM 測試對改善新生兒結局的效果。此外，2021 年 5 月，Thera Prognostics 宣布與 Anthem 建立新的戰略商業合作夥伴關係，作為多年協議的一部分，向懷孕會員提供 PreTRM 測試。該合作夥伴關係將為美國更多的醫生和患者帶來早期和準確的早產預測，使他們能夠在懷孕期間做出更明智的決定。同樣，2021 年 10 月，倫敦帝國理工學院 March of Dimes 早產兒研究中心的研究人員將開發出世界上第一個有助於推進早產診斷和治療的測試。

此外，美國酒精和非法藥物消費的增加也導致早產發生率增加。根據美國疾病控制和預防中心發布的數據，2022 年，14% 的孕婦報告當前飲酒，5% 報告暴飲暴食。

因此，預計在預測期內，早產率的上升以及專注於開發測試套件和設備的公司和組織將推動該地區的市場增長。

競爭格局

市場競爭激烈，有大量全球和本地參與者。主要參與者正在採取各種增長戰略，例如新產品開發、產品差異化戰略和擴張，以保持其市場地位。公司包括 Hologic, Inc.、Abbott、Sera Prognostics Inc.、CooperSurgical Inc. 和 IQ Products。

其他特典

  • Excel 格式的市場預測 (ME) 表
  • 三個月的分析師支持

內容

第 1 章介紹

  • 研究假設和市場定義
  • 調查範圍

第 2 章研究方法論

第 3 章執行摘要

第 4 章市場動態

  • 市場概覽
  • 市場促進因素
    • 早產和低出生體重的發生率增加
    • 提高了對床旁檢測和 PROM 檢測的認識並取得了技術進步
  • 市場抑制因素
    • 欠發達國家缺乏意識和經濟限制
  • 波特的五力分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分（基於價值的市場規模：100 萬美元）

  • 按測試類型
    • 盆腔檢查
    • 超音波檢查
    • 生化標記
    • 子宮監測
    • 其他
  • 按地區
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲地區
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東和非洲
      • 海灣合作委員會
      • 南非
      • 其他中東地區
    • 南美洲地區
      • 巴西
      • 阿根廷
      • 其他南美洲

第 6 章競爭格局

  • 公司簡介
    • Hologic, Inc
    • Abbott
    • Sera Prognostics Inc.
    • CooperSurgical Inc.
    • IQ Products
    • Qiagen N.V.
    • Biosynex
    • LifeCell International Pvt. Ltd.
    • Clinical Innovations, Inc.
    • NX Prenatal, Inc.

第 7 章市場機會與未來趨勢

簡介目錄
Product Code: 90789

The Preterm Birth and PROM testing market is projected to grow with a CAGR of 3.35% during the forecast period (2022 - 2027).

The COVID-19 pandemic has significantly impacted the preterm birth and PROM testing market. According to a study published in the International Journal of Gynecology and Obstetrics, in October 2020, titled "The effect of the COVID-19 pandemic on maternal health due to delay in seeking health care: Experience from a tertiary center," inadequate prenatal visits were observed in one-third of the women. Lockdown and fear of infection were the leading causes of delayed health-seeking, with 44.7% of pregnancies ending in complications. Also, according to a report published in the Gynecologic and Obstetric Investigation in July 2020, infection with COVID-19 during pregnancy raises the risk of pregnancy complications such as preterm birth, preterm premature rupture of the membranes, and, in rare circumstances, maternal mortality. As a result, preterm and PROM testing have been increased to detect and prevent prenatal births and reduce complications. Thus, the market is predicted to rise due to the increased need for care.

The factors propelling the growth of the market are the rising number of preterm and low-weight births worldwide, growing advancements in point-of-care diagnostics and technological advancements in PROM testing tools, and increasing awareness regarding preterm birth and PROM testing availability.

The incidences of premature birth and increasing death among children due to preterm birth are the key driving factors for the growth of the market over the forecast period. According to the data published by the Centers for Disease Control, in 2021, the rate of preterm delivery among African-American women was 14.9%, which is 50% higher than the rate among whites (9.1%) and Hispanic women (9.8%). Similarly, according to the statistics published by the March of Dimes, in 2021, it has been observed that the preterm birth rates rose from 14.25% to 14.36% among Black women and from 11.55% to 11.61% among American Indian/Alaska Native mothers. Additionally, an article published by the Centers for Disease Control and Prevention in 2021, titled 'Preterm Birth,' reported that in 2020, in the United States, one in every ten infants born were premature.

Furthermore, the increasing number of people visiting diagnostic labs and healthcare units for testing, particularly in emerging regions, is fueling market expansion over the forecast period. Diagnostic centers are becoming more popular and widely used due to their increased reliability, cost-effectiveness, speed of results, and delivering precise diagnosis results at a low cost.

However, the lack of availability of PROM testing services and economic constraints in under-der developed countries are likely to hinder the growth of the market.

Key Market Trends

Ultrasound Segment Expects to Register a High CAGR in the Forecast Period

The ultrasound segment is witnessing significant growth in the forecast period owing to the factors such as increased incidences of preterm birth, increasing company research and development activities, and technological advancements to detect and predict preterm births.

Ultrasound can be used to check cervical tissue, as it generates images of the uterus and the baby, which can be used to identify if the cervix has dilated or effaced, as well as to improve diagnosis and forecast premature births.

With increased incidences of preterm births and associated consequences, pregnant women are more likely to engage in preterm testing during pregnancy for reassurance and monitoring of preterm birth symptoms and to avoid preterm deaths. For instance, according to an article published by the American Family Physician, in 2020, it has been observed that about 3% of pregnancies are complicated by preterm PROM, and one-third of preterm deliveries are caused by it. It raises the risk of preterm and causes several other perinatal and neonatal issues, including a 1% to 2% chance of fetal death.

The increasing company focus on developing tests and devices to predict preterm birth is also contributing to the growth of the ultrasound segment, thereby increasing the market growth. For instance, in March 2022, Ultrasound AI Inc. will use ultrasound technology and artificial intelligence to anticipate preterm birth and allow for earlier interventions. In addition, in May 2021, DC Medical developed a portable preterm diagnostic device, EveryBaby, after researching Electrical Impedance Spectroscopy (EIS) at the University of Sheffield, which could potentially improve the prediction of preterm birth. In August 2020, PulseNmore, an Israeli startup, launched a handheld tele-ultrasound device that allows pregnant women to conduct ultrasound exams at home and receive feedback from a physician or sonographer.

Thus, with the increased incidence and risk associated with preterm births and the technological advancements, the demand for the ultrasound segment is likely to increase in the forecast period.

North America is Expected to Have the Significant Market Share

North America is anticipated to have a significant share in the market owing to the factors such as increased demand for pre-birth testing due to the increased incidence of preterm births, rising technical breakthroughs, and well-established healthcare facilities in the region.

In addition, the company, as well as non-profit organizations, are focusing on developing tests and devices for evaluating and detecting preterm births in the region and contributing to the market's growth. For instance, In January 2021, Sera Prognostics, Inc. partnered with HealthCore, Inc. and Anthem, Inc. to launch the PRIME study to evaluate the effectiveness of the PreTRM test with clinical interventions to improve neonatal outcomes. In addition, In May 2021, Sera Prognostics announced a novel strategic commercial partnership with Anthem to make PreTRM Tests available to pregnant members as part of a multi-year contract. Through this partnership, many physicians and patients in the United States will have access to early and accurate preterm birth predictions, allowing them to make more informed decisions during pregnancy. Similarly, in October 2021, the researchers at the March of Dimes Prematurity Research Center at Imperial College London developed a first-of-its-kind testing device that may help advance the diagnosis and treatment of preterm birth.

Moreover, increased intake of alcohol and illicit drugs is also contributing to a rise in the incidence of preterm births in the United States. According to the data published by the Centers for Disease Control, in 2022, 14% of pregnant females reported current drinking, and 5% reported binge drinking.

Thus, increasing rates of preterm births and companies and organizations focusing on developing testing kits and devices are likely to increase the market growth in the region over the forecast period.

Competitive Landscape

The market is highly competitive with many global and local players. The major companies are adopting different growth strategies such as new product development, product differentiation strategies, and expansion to withhold the market position. Some players are Hologic, Inc., Abbott, Sera Prognostics Inc., CooperSurgical Inc., and IQ Products.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Incidence of Preterm and Low-weight Births
    • 4.2.2 Increasing Awareness and Technological Advancements in Point-Of Care and PROM Testing
  • 4.3 Market Restraints
    • 4.3.1 Lack of Awareness and Economic Constraints in Under-developed Countries
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Test Type
    • 5.1.1 Pelvic exam
    • 5.1.2 Ultrasound
    • 5.1.3 Biochemical Markers
    • 5.1.4 Uterine Monitoring
    • 5.1.5 Others
  • 5.2 Geography
    • 5.2.1 North America
      • 5.2.1.1 United States
      • 5.2.1.2 Canada
      • 5.2.1.3 Mexico
    • 5.2.2 Europe
      • 5.2.2.1 Germany
      • 5.2.2.2 United Kingdom
      • 5.2.2.3 France
      • 5.2.2.4 Italy
      • 5.2.2.5 Spain
      • 5.2.2.6 Rest of Europe
    • 5.2.3 Asia-Pacific
      • 5.2.3.1 China
      • 5.2.3.2 Japan
      • 5.2.3.3 India
      • 5.2.3.4 Australia
      • 5.2.3.5 South Korea
      • 5.2.3.6 Rest of Asia-Pacific
    • 5.2.4 Middle East and Africa
      • 5.2.4.1 GCC
      • 5.2.4.2 South Africa
      • 5.2.4.3 Rest of Middle East and Africa
    • 5.2.5 South America
      • 5.2.5.1 Brazil
      • 5.2.5.2 Argentina
      • 5.2.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Hologic, Inc
    • 6.1.2 Abbott
    • 6.1.3 Sera Prognostics Inc.
    • 6.1.4 CooperSurgical Inc.
    • 6.1.5 IQ Products
    • 6.1.6 Qiagen N.V.
    • 6.1.7 Biosynex
    • 6.1.8 LifeCell International Pvt. Ltd.
    • 6.1.9 Clinical Innovations, Inc.
    • 6.1.10 NX Prenatal, Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS